Skip to content
2000
Volume 5, Issue 10
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The actions of the neuropeptide corticotropin-releasing factor (CRF) are modulated by a CRF binding protein (CRFBP). In view of the memory-enhancing effects of CRF, the release of endogenous CRF from CRFBP by CRFBP inhibitors has been suggested as a therapeutical strategy for the treatment of cognitive deficits. This mini-review will summarize recent advances in the field with a focus on the pharmaceutical potential of CRFBP inhibitors.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955705774329500
2005-10-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955705774329500
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test